A detailed history of Srs Capital Advisors, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 1,464 shares of VTRS stock, worth $19,032. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,464
Previous 1,301 12.53%
Holding current value
$19,032
Previous $13,000 23.08%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$10.32 - $12.13 $1,682 - $1,977
163 Added 12.53%
1,464 $16,000
Q2 2024

Aug 06, 2024

BUY
$10.05 - $12.02 $11,668 - $13,955
1,161 Added 829.29%
1,301 $13,000
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $135 - $162
-12 Reduced 7.89%
140 $1,000
Q4 2023

Feb 06, 2024

SELL
$8.77 - $10.85 $2,394 - $2,962
-273 Reduced 64.24%
152 $1,000
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $38 - $45
4 Added 0.95%
425 $4,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $27 - $30
3 Added 0.72%
421 $4,000
Q1 2023

May 16, 2023

BUY
$9.2 - $12.26 $27 - $36
3 Added 0.72%
418 $4,000
Q4 2022

Feb 24, 2023

SELL
$8.72 - $11.56 $58,005 - $76,897
-6,652 Reduced 94.13%
415 $4,000
Q3 2022

Nov 03, 2022

SELL
$8.48 - $11.13 $2,026 - $2,660
-239 Reduced 3.27%
7,067 $60,000
Q2 2022

Aug 22, 2022

BUY
$9.95 - $12.27 $776 - $957
78 Added 1.08%
7,306 $76,000
Q1 2022

May 12, 2022

BUY
$9.81 - $15.4 $29 - $46
3 Added 0.04%
7,228 $79,000
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $12 - $14
1 Added 0.01%
7,225 $98,000
Q3 2021

Nov 05, 2021

BUY
$13.25 - $15.13 $18,338 - $20,939
1,384 Added 23.7%
7,224 $98,000
Q2 2021

Aug 02, 2021

BUY
$12.97 - $16.15 $59,143 - $73,644
4,560 Added 356.25%
5,840 $83,000
Q4 2020

Feb 03, 2021

BUY
$14.3 - $18.74 $18,304 - $23,987
1,280 New
1,280 $24,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Srs Capital Advisors, Inc. Portfolio

Follow Srs Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.